跳轉至內容

MTOXCE2C19

CypExpress 2C19 Cytochrome P450 human

同義詞:

CPCJ, CYP2C, CYP2C19, P450 2C19, P450C2C, P450IIC19

登入 檢視組織與合約價格。

選擇尺寸

變更視圖

關於此項目

UNSPSC Code:
41106200
EC Number:
232-387-9
NACRES:
NA.77
Form:
dry powder
Biological source:
human
Recombinant:
expressed in Pichia pastoris
技術服務
需要援助?我們經驗豐富的科學家團隊隨時樂意為您提供支援。
讓我們為您提供幫助


biological source

human

recombinant

expressed in Pichia pastoris

form

dry powder

UniProt accession no.

application(s)

cell analysis

shipped in

dry ice

storage temp.

−70°C

Gene Information

human ... CYP2C19(1557)

Biochem/physiol Actions

Cytochrome P450 enzymes are heme containing monooxygenases which are found primarily in the mammalian liver. They catalyze the oxidative metabolism of xenobiotics. This metabolism is the initial step in the biotransformation and elimination of a wide variety of drugs and environmental pollutants from the body. ticlopidine and nootkatone are inhibitors, whereas rifampin is an inducer of the enzyme. The isozyme CYP2C19 is a major pathway for the conversion of S-Mephenytoin to S-4-Hydroxymephenytoin via hydroxylation.
Cytochrome P450 is a heterogeneous family of isozymes whose primary function is to oxidize small molecules, both as a function of intermediary metabolism (e.g., fatty acids) and to detoxify exogenous compounds (drugs or toxins). Some isoforms have narrow substrate specificity, while others are promiscuous.

Features and Benefits

CypExpress 2C19 is a permeabilized and stabilized dried yeast powder preparation containing full length, unmodified, human CYP 2C19 and recombinant human NADPH oxidoreductase. Using proprietary processes, CypExpress are expressed in Pichia yeast. Following optimal expression, the cells are inactivated, permeabilized and dried to a fine powder. CypExpress retains the cellular mechanisms to provide the P450 enzymes with the energy and cofactors to continue to function for long experiments, and can generate larger amounts of metabolite than mammalian microsomes or other genetically engineered expression systems.It is designed for rapid screening of drug metabolites and for scaling up metabolite generation.

Physical form

Light yellow, very fine powder

Preparation Note

Per Protocol/Variable

Other Notes

A reaction mixture containing 500 μM mephenytoin and 100 mg/mL of CypExpress 2C19 will produce 42.76 μM 4-hydroxymephenytoin in 4 hours at 30°C under the conditions described.

Legal Information

CypExpress is a trademark of Oxford Biomedical Research


存儲類別/等級

11 - Combustible Solids

到底發生了什麼事?

WGK 1

閃點 (F)

Not applicable

閃點(°C)

Not applicable



從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

未看到正確版本?

如果您需要一個特定的版本,您可以透過批號來尋找特定憑證。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫